SPONSOR
Sichuan Huiyu Pharmaceutical Co., Ltd
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
NCT06712680 Phase 1, Phase 2
Recruiting
A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes
Solid Tumor
NCT07083323 Phase 1, Phase 2
Recruiting
A Phase I/II Study of HY05350 in Mesothelin(MSLN)-Positive Advanced Solid Tumors
Advanced Solid Tumor